✦ LIBER ✦

The Cost-Effectiveness of Dabigatran and the Opportunity Cost of Delayed Subsidised Access in Australia

✍ Scribed by Tilden, D.; Germanos, P.; Gordon, J.; Tocchini, L.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Effectiveness and Cost Effectiveness

✍ Roger A. Winkle 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

The cost-effectiveness of rotavirus vacc

✍ Anthony T. Newall; Philippe Beutels; Kristine Macartney; James Wood; C. Raina Ma 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 425 KB

The cost-effectiveness of pneumococcal c

✍ James R.G Butler; Peter McIntyre; C Raina MacIntyre; Robin Gilmour; Ann L Howart 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 131 KB

PCV60 Cost-Effectiveness of Dabigatran f

✍ D. Tilden; P. Germanos; J. Gordon; L. Tocchini; B. Monz 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

The Cost-Effectiveness of Apixaban Compa

✍ Kelly, J.; Griffith, G.; Fortune, P.; Lister, S. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

The Cost-Effectiveness of Mandatory Foli

✍ Rabovskaja, V.; Parkinson, B.; Goodall, S. 📂 Article 📅 2012 🏛 American Society for Nutritional Sciences 🌐 English ⚖ 666 KB